Correlation Between Vertex Pharmaceuticals and Editas Medicine

Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vertex Pharmaceuticals and Editas Medicine, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Editas Medicine.

Diversification Opportunities for Vertex Pharmaceuticals and Editas Medicine

0.4

Correlation Coefficient

Vertex Pharmaceuticals  Editas Medicine

Very weak diversification

The 3 months correlation between Vertex and Editas is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Editas Medicine go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Editas Medicine

Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 13.98 times less return on investment than Editas Medicine. But when comparing it to its historical volatility, Vertex Pharmaceuticals is 4.08 times less risky than Editas Medicine. It trades about 0.06 of its potential returns per unit of risk. Editas Medicine is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  133.00  in Editas Medicine on May 6, 2025 and sell it today you would earn a total of  123.00  from holding Editas Medicine or generate 92.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Vertex Pharmaceuticals  vs.  Editas Medicine

Vertex Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Editas Medicine

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Editas Medicine are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, Editas Medicine unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vertex Pharmaceuticals and Editas Medicine

The main advantage of trading using opposite Vertex Pharmaceuticals and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.

The idea behind Vertex Pharmaceuticals and Editas Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.